Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Newmark management to meet virtually with Piper Sandler » 07:40
05/26/20
05/26
07:40
05/26/20
07:40
NMRK

Newmark

$3.74 /

-0.17 (-4.35%)

Virtual Meeting to be…

Virtual Meeting to be held on May 26 hosted by Piper Sandler.

ShowHide Related Items >><<
NMRK Newmark
$3.74 /

-0.17 (-4.35%)

NMRK Newmark
$3.74 /

-0.17 (-4.35%)

04/09/20 BofA
Newmark double-downgraded to Underperform from Buy at BofA
04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
NMRK Newmark
$3.74 /

-0.17 (-4.35%)

Earnings
Newmark withdraws 2020 guidance  08:08
05/07/20
05/07
08:08
05/07/20
08:08
NMRK

Newmark

$3.51 /

-0.3 (-7.87%)

 
ShowHide Related Items >><<
NMRK Newmark
$3.51 /

-0.3 (-7.87%)

04/09/20 BofA
Newmark double-downgraded to Underperform from Buy at BofA
04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
Earnings
Newmark reports Q1 adjusted EPS 9c, consensus 23c » 08:07
05/07/20
05/07
08:07
05/07/20
08:07
NMRK

Newmark

$3.51 /

-0.3 (-7.87%)

Reports Q1 revenue…

Reports Q1 revenue $483.9M, consensus $494.43M.

ShowHide Related Items >><<
NMRK Newmark
$3.51 /

-0.3 (-7.87%)

04/09/20 BofA
Newmark double-downgraded to Underperform from Buy at BofA
04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
Hot Stocks
Newmark announces certain pay reductions » 08:03
04/28/20
04/28
08:03
04/28/20
08:03
NMRK

Newmark

$3.85 /

+0.34 (+9.69%)

Newmark Group announced…

Newmark Group announced certain pay reductions due to the impact of the SARS-CoV-2 pandemic. In response to the continuing macroeconomic impact of the pandemic, Newmark's executive officers have volunteered to reduce their base salaries. Chairman Howard W. Lutnick and CEO Barry M. Gosin will each reduce his annual base salary by 50%, while CFO Michael J. Rispoli, Chief Legal Officer Stephen M. Merkel, and any senior managers who are direct reports to Mr. Gosin will reduce their annual base salaries by 15%. On April 27 the Compensation Committee of the Board of Directors agreed to these changes to executive officer compensation. In addition, the independent members of the Board volunteered to forego 15% of his or her annual cash retainer. All the above compensation reductions are effective immediately and will remain in place until December 31.

ShowHide Related Items >><<
NMRK Newmark
$3.85 /

+0.34 (+9.69%)

04/09/20 BofA
Newmark double-downgraded to Underperform from Buy at BofA
04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
Over a quarter ago
Downgrade
Newmark double-downgraded to Underperform from Buy at BofA » 06:19
04/09/20
04/09
06:19
04/09/20
06:19
NMRK

Newmark

$3.76 /

+0.34 (+9.94%)

BofA analyst Michael Funk…

BofA analyst Michael Funk double-downgraded Newmark to Underperform from Buy with a $4 price target. The analyst cites the expected impact of a deeper and longer recession, along with that of the stay at home order, on transactional advisory leasing and advisory capital market revenue. Funk further notes uncertainty regarding mortgage servicing industry and the company's weaker liquidity position, reducing his FY20 revenue forecast by 31% to $1.65B and adj. EBITDA view by 34% to $378M.

ShowHide Related Items >><<
NMRK Newmark
$3.76 /

+0.34 (+9.94%)

04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
10/18/19 BofA
Newmark reinstated with a Buy at BofA/Merrill
Downgrade
Newmark downgraded to Underperform from Buy at BofA » 06:05
04/09/20
04/09
06:05
04/09/20
06:05
NMRK

Newmark

$3.76 /

+0.34 (+9.94%)

BofA analyst Michael Funk…

BofA analyst Michael Funk downgraded Newmark to Underperform from Buy.

ShowHide Related Items >><<
NMRK Newmark
$3.76 /

+0.34 (+9.94%)

02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
10/18/19 BofA
Newmark reinstated with a Buy at BofA/Merrill
07/10/19 Compass Point
Newmark initiated with a Buy at Compass Point
Conference/Events
Newmark management to meet with Morgan Stanley » 04:55
03/10/20
03/10
04:55
03/10/20
04:55
NMRK

Newmark

$7.45 /

-1.33 (-15.15%)

Dinner Meeting to be held…

Dinner Meeting to be held in the New York on March 10 hosted by Morgan Stanley.

ShowHide Related Items >><<
NMRK Newmark
$7.45 /

-1.33 (-15.15%)

02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
10/18/19 BofA
Newmark reinstated with a Buy at BofA/Merrill
07/10/19 Compass Point
Newmark initiated with a Buy at Compass Point
Conference/Events
Newmark management to meet with Morgan Stanley » 09:21
03/06/20
03/06
09:21
03/06/20
09:21
NMRK

Newmark

$9.23 /

-0.48 (-4.94%)

Dinner Meeting to be held…

Dinner Meeting to be held in the New York on March 10 hosted by Morgan Stanley.

ShowHide Related Items >><<
NMRK Newmark
$9.23 /

-0.48 (-4.94%)

02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
10/18/19 BofA
Newmark reinstated with a Buy at BofA/Merrill
07/10/19 Compass Point
Newmark initiated with a Buy at Compass Point
Hot Stocks
Paulson adds Pretium, exits United Tech in Q4 » 17:06
02/14/20
02/14
17:06
02/14/20
17:06
PVG

Pretium Resources

$7.42 /

-0.035 (-0.47%)

, TECD

Tech Data

$144.08 /

+0.02 (+0.01%)

, TIF

Tiffany

$134.27 /

-0.1 (-0.07%)

, LOGM

LogMeln

$85.51 /

+0.06 (+0.07%)

, CPE

Callon Petroleum

$2.89 /

-0.015 (-0.52%)

, UTX

Merged into RTX

$153.47 /

+0.395 (+0.26%)

, PCG

PG&E

$16.19 /

-0.57 (-3.40%)

, INSW

International Seaways

$21.21 /

-0.035 (-0.16%)

, LYFT

Lyft

$44.68 /

-2.345 (-4.99%)

, S

Sprint

$8.70 /

+0.03 (+0.35%)

, GOLD

Barrick Gold

$19.73 /

+0.79 (+4.17%)

, SES

Synthesis Energy Systems

$5.56 /

+0.04 (+0.72%)

, CZR

Caesars

$14.59 /

+0.13 (+0.90%)

, QEP

QEP Resources

$2.72 /

-0.135 (-4.74%)

, NMRK

Newmark

$11.46 /

-0.31 (-2.63%)

, AGN

Bought by ABBV

$198.24 /

-0.9 (-0.45%)

, BHC

Bausch Health

$27.74 /

+0.305 (+1.11%)

, GLD

SPDR Gold Shares

$148.99 /

+0.63 (+0.42%)

, DISCK

Discovery Inc.

$28.74 /

-0.15 (-0.52%)

, HZNP

Horizon Therapeutics

$35.95 /

+0.09 (+0.25%)

John Paulson's…

John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of December 31, 2019. The fund's six new buys during the fourth quarter included, by size of position, Pretium Resources (PVG), Tech Data (TECD), Tiffany (TIF), and LogMeIn (LOGM). Paulson exited 13 positions during the quarter, including by size of previous position Callon Petroleum (CPE), United Technologies (UTX), PG&E (PCG), International Seaways (INSW), and Lyft (LYFT). The fund increased its stake in three holdings, including by size of previous position Sprint (S), Barrick Gold (GOLD), and Synthesis Energy Systems (SES). Paulson reduced its stake in five holdings, including by size of previous position Caesars Entertainment (CZR), QEP Resources (QEP), Newmark Group (NMRK), and Allergan (AGN). The fund's top holdings as of December 31, in order of size, were Bausch Health (BHC), SPDR Gold Shares (GLD), Allergan, Discovery Class C (DISCK), and Horizon Therapeutics (HZNP).

ShowHide Related Items >><<
PVG Pretium Resources
$7.42 /

-0.035 (-0.47%)

02/13/20
Fly Intel: Top five analyst downgrades
02/13/20 Canaccord
Canaccord downgrades Pretium Resources, negative outlook cited
02/13/20 H.C. Wainwright
Pretium Resources price target lowered to $15 from $20.50 at H.C. Wainwright
02/12/20 Canaccord
Pretium Resources downgraded to Hold from Speculative Buy at Canaccord
TECD Tech Data
$144.08 /

+0.02 (+0.01%)

12/10/19 Northcoast
Tech Data downgraded to Neutral from Buy at Northcoast
10/17/19 Loop Capital
Tech Data price target raised to $150 from $130 at Loop Capital
10/16/19 Stifel
Tech Data investors likely to want higher takeout price, says Stifel
09/12/19 Loop Capital
Tech Data price target raised to $130 from $120 at Loop Capital
TIF Tiffany
$134.27 /

-0.1 (-0.07%)

12/09/19 Cowen
Tiffany downgraded to Market Perform from Outperform at Cowen
12/06/19
Fly Intel: Top five analyst downgrades
12/06/19 Loop Capital
Tiffany price target raised to $135 from $85 at Loop Capital
12/06/19 Credit Suisse
Tiffany's best path forward likely the LVMH deal, says Credit Suisse
LOGM LogMeln
$85.51 /

+0.06 (+0.07%)

01/15/20 Piper Sandler
Piper introduces long VMware, short Juniper pair trade into Q4 results
01/03/20
Fly Intel: Top five analyst downgrades
01/03/20
LogMeln downgraded to Sector Weight from Overweight at KeyBanc
01/02/20 KeyBanc
LogMeln downgraded to Sector Weight from Overweight at KeyBanc
CPE Callon Petroleum
$2.89 /

-0.015 (-0.52%)

02/05/20 Barclays
Callon Petroleum downgraded to Equal Weight from Overweight at Barclays
01/23/20 Credit Suisse
Credit Suisse says 'moving to the sidelines' on Callon Petroleum
01/22/20 Credit Suisse
Callon Petroleum downgraded to Neutral from Outperform at Credit Suisse
12/23/19 Imperial Capital
Callon Petroleum price target raised to $13 from $10 at Imperial Capital
UTX Merged into RTX
$153.47 /

+0.395 (+0.26%)

02/04/20 Gabelli
General Electric Q4 results confirm positive trajectory, says Gabelli
01/31/20 Benchmark
Benchmark starts United Technologies at Buy ahead of 'historic' split
01/31/20 Benchmark
United Technologies initiated with a Buy at Benchmark
01/29/20 Argus
United Technologies price target raised to $170 from $155 at Argus
PCG PG&E
$16.19 /

-0.57 (-3.40%)

01/28/20 Mizuho
PG&E upgraded to Buy from Neutral at Mizuho
01/15/20
Fly Intel: Top five analyst upgrades
01/15/20 Citi
PG&E upgraded to Buy from Neutral at Citi
01/15/20 Citi
PG&E upgraded to Buy from Neutral at Citi
INSW International Seaways
$21.21 /

-0.035 (-0.16%)

01/08/20 B. Riley FBR
B. Riley FBR sees another strong year for tanker stocks in 2020
11/05/19 BTIG
BTIG raises price targets on tanker shipping names
10/11/19 BTIG
International Seaways initiated with a Buy rating at BTIG
04/24/19 Stifel
U.S. sanctions on Iran could benefit crude tankers, says Stifel
LYFT Lyft
$44.68 /

-2.345 (-4.99%)

02/12/20 DA Davidson
Lyft price target lowered to $63 from $75 at DA Davidson
02/12/20 Morgan Stanley
Morgan Stanley continues to prefer Uber after Lyft report
02/12/20 JPMorgan
Lyft earnings selloff a buying opportunity, says JPMorgan
02/12/20 RBC Capital
Lyft price target lowered to $75 from $82 at RBC Capital
S Sprint
$8.70 /

+0.03 (+0.35%)

02/13/20 HSBC
SoftBank price target raised to 7,000 yen after Sprint deal approval
02/12/20 Argus
T-Mobile price target raised to $105 from $93 at Argus
02/12/20 Credit Suisse
T-Mobile, Sprint merger negative for AT&T/Verizon, says Credit Suisse
02/12/20 Credit Suisse
CommScope positioned to benefit from Sprint/T-Mobile deal, says Credit Suisse
GOLD Barrick Gold
$19.73 /

+0.79 (+4.17%)

01/15/20 Credit Suisse
Agnico, Newmont, Endeavour named top 2020 gold picks at Credit Suisse
01/15/20 Credit Suisse
Barrick Gold upgraded to Outperform from Neutral at Credit Suisse
01/15/20 Credit Suisse
Barrick Gold upgraded to Outperform from Neutral at Credit Suisse
01/09/20 Deutsche Bank
Pan American Silver downgraded to Hold from Buy at Deutsche Bank
SES Synthesis Energy Systems
$5.56 /

+0.04 (+0.72%)

CZR Caesars
$14.59 /

+0.13 (+0.90%)

01/08/20 Stifel
Eldorado Resorts named top Gaming & Leisure idea for 2020 at Stifel
11/19/19 Morgan Stanley
Eldorado Resorts initiated with an Overweight at Morgan Stanley
08/26/19
VICI Properties raised to Overweight at Morgan Stanley on non-gaming opportunity
07/01/19 Deutsche Bank
Eldorado Resorts price target raised to $74 from $56 at Deutsche Bank
QEP QEP Resources
$2.72 /

-0.135 (-4.74%)

10/30/19 Stephens
QEP Resources upgraded to Overweight on successful execution at Stephens
10/30/19 Stephens
QEP Resources upgraded to Overweight from Equal Weight at Stephens
10/28/19 Piper Sandler
QEP Resources upgraded to Overweight from Neutral at Piper Jaffray
10/24/19 Williams Capital
QEP Resources upgraded to Buy from Hold at Williams Capital
NMRK Newmark
$11.46 /

-0.31 (-2.63%)

02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
10/18/19 BofA
Newmark reinstated with a Buy at BofA/Merrill
07/10/19 Compass Point
Newmark initiated with a Buy at Compass Point
AGN Bought by ABBV
$198.24 /

-0.9 (-0.45%)

02/14/20 Piper Sandler
Piper says Ubrelvy prescription trajectory bodes well for Biohaven's rimegepant
02/11/20 SunTrust
Allergan price target raised to $202 from $194 at SunTrust
02/03/20 Oppenheimer
Eyenovia downgraded to Perform from Outperform at Oppenheimer
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
BHC Bausch Health
$27.74 /

+0.305 (+1.11%)

01/29/20 Wolfe Research
Bausch Health downgraded to Peer Perform from Outperform at Wolfe Research
01/22/20 Wells Fargo
Bausch Health upgraded to Equal Weight from Underweight at Wells Fargo
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
GLD SPDR Gold Shares
$148.99 /

+0.63 (+0.42%)

DISCK Discovery Inc.
$28.74 /

-0.15 (-0.52%)

HZNP Horizon Therapeutics
$35.95 /

+0.09 (+0.25%)

01/22/20 BMO Capital
Horizon Therapeutics price target raised to $46 from $40 at BMO Capita
01/22/20 Guggenheim
Horizon's label for Tepezza 'broad and incredibly clean,' says Guggenheim
01/14/20 JMP Securities
Horizon Therapeutics price target raised to $47 from $38 at JMP Securities
01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
Downgrade
Newmark downgraded to Neutral from Outperform at Wedbush » 07:34
02/14/20
02/14
07:34
02/14/20
07:34
NMRK

Newmark

$11.77 /

-0.29 (-2.40%)

Wedbush analyst Henry…

Wedbush analyst Henry Coffey downgraded Newmark to Neutral from Outperform with a price target of $12.35, down from $13, following the company's Q4 results. In a research note to investors, Coffey says the company indicated on its earnings call that it expects to see flat to down leasing and other related revenue and that while it is expecting growth in management and services income, it is a hard area to expand.

ShowHide Related Items >><<
NMRK Newmark
$11.77 /

-0.29 (-2.40%)

02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
10/18/19 BofA
Newmark reinstated with a Buy at BofA/Merrill
07/10/19 Compass Point
Newmark initiated with a Buy at Compass Point
05/09/19
Newmark reports Q1 adjusted EPS 21c, consensus 23c

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.